Literature DB >> 16145544

Early ocular chemokine gene expression and leukocyte infiltration after high-risk corneal transplantation.

Satoru Yamagami1, Pedram Hamrah, Qiang Zhang, Ying Liu, Syed Huq, M Reza Dana.   

Abstract

PURPOSE: To determine the differential gene expression of chemokine species and leukocyte infiltration of grafts in the early pre-rejection postoperative period after high-risk (HR) compared to normal-risk (NR) corneal transplantation.
METHODS: Fully mismatched and syngeneic corneal grafts were performed in NR (avascular) and HR (vascularized) recipient beds of BALB/c murine hosts. Gene expression levels of a panel of chemokines were determined by a multiprobe ribonuclease protection assay system. The profiles of infiltrating cells into the corneal grafts at the same times were determined immunohistochemically.
RESULTS: Compared to NR transplantation, HR eyes exhibited significantly higher mRNA levels for macrophage inflammatory protein (MIP)-2 and monocyte chemotactic protein-1 (MCP-1) on day 1, and for eotaxin on days 1 and 3 after transplantation. By day 6 after transplantation, still well before graft rejection, significantly higher levels of RANTES, eotaxin, MIP-1alpha, MIP-1beta, MIP-2, and MCP-1 were detected in HR eyes. The overexpression of MIPs in HR eyes correlated with a significant increase in the number of infiltrating macrophages (p<0.01), and neutrophils (p<0.05) in HR compared to NR recipients. Low levels of eosinophil and mast cell infiltration were observed in all grafts, with a modest increase in mast cell infiltration (p<0.05) in HR compared to NR grafts.
CONCLUSIONS: These results suggest that increased expression of gene products for select chemokines, in particular those that mediate recruitment of innate immune cells, in the early period after HR corneal transplantation is related to the enhanced leukocytic infiltration of grafts observed in HR keratoplasty.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16145544

Source DB:  PubMed          Journal:  Mol Vis        ISSN: 1090-0535            Impact factor:   2.367


  16 in total

1.  E-Selectin Mediates Immune Cell Trafficking in Corneal Transplantation.

Authors:  Thomas H Dohlman; Antonio Di Zazzo; Masahiro Omoto; Jing Hua; Julia Ding; Pedram Hamrah; Sunil K Chauhan; Reza Dana
Journal:  Transplantation       Date:  2016-04       Impact factor: 4.939

2.  Effect of sorafenib in a murine high risk penetrating keratoplasty model.

Authors:  Yang Kyung Cho; Eun Young Shin; Hironori Uehara; Balamurali K Ambati
Journal:  Int J Ophthalmol       Date:  2017-06-18       Impact factor: 1.779

Review 3.  Ocular surface immunity: homeostatic mechanisms and their disruption in dry eye disease.

Authors:  Stefano Barabino; Yihe Chen; Sunil Chauhan; Reza Dana
Journal:  Prog Retin Eye Res       Date:  2012-03-08       Impact factor: 21.198

Review 4.  High-risk corneal allografts: A therapeutic challenge.

Authors:  Tian Yu; Vijayalakshmi Rajendran; May Griffith; John V Forrester; Lucia Kuffová
Journal:  World J Transplant       Date:  2016-03-24

5.  Presurgical corticosteroid treatment improves corneal transplant survival in mice.

Authors:  Hyun Kyung Kim; Jin A Choi; Hironori Uehara; Xiaohui Zhang; Balamurali K Ambati; Yang Kyung Cho
Journal:  Cornea       Date:  2013-12       Impact factor: 2.651

6.  Effects of immunosuppressants after penetrating keratoplasty: meta-analysis of randomized controlled trials.

Authors:  Xin Wei; Xiao-Ming Chen; Lin Wang; Jin-Ping Song; Yin-Ping Deng
Journal:  Int J Ophthalmol       Date:  2011-10-18       Impact factor: 1.779

7.  CCR7 is critical for the induction and maintenance of Th17 immunity in dry eye disease.

Authors:  Shilpa Kodati; Sunil K Chauhan; Yihe Chen; Thomas H Dohlman; Parisa Karimian; Daniel Saban; Reza Dana
Journal:  Invest Ophthalmol Vis Sci       Date:  2014-08-19       Impact factor: 4.799

8.  Vascular Endothelial Growth Factor Receptor 1 morpholino increases graft survival in a murine penetrating keratoplasty model.

Authors:  Yang Kyung Cho; Xiaohui Zhang; Hironori Uehara; Jason R Young; Bonnie Archer; Balamurali Ambati
Journal:  Invest Ophthalmol Vis Sci       Date:  2012-12-19       Impact factor: 4.799

Review 9.  Alloimmunity and Tolerance in Corneal Transplantation.

Authors:  Afsaneh Amouzegar; Sunil K Chauhan; Reza Dana
Journal:  J Immunol       Date:  2016-05-15       Impact factor: 5.422

10.  Comparison of topical interleukin-1 vs tumor necrosis factor-alpha blockade with corticosteroid therapy on murine corneal inflammation, neovascularization, and transplant survival (an American Ophthalmological Society thesis).

Authors:  Reza Dana
Journal:  Trans Am Ophthalmol Soc       Date:  2007
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.